Is endometrial carcinoma intrinsically more aggressive in elderly patients?

被引:76
作者
Alektiar, KM
Venkatraman, E
Abu-Rustum, N
Barakat, RR
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Biostat, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA
关键词
endometrial carcinoma; elderly; radiation therapy; outcome;
D O I
10.1002/cncr.11830
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. The current study was conducted to determine the influence of old age (age greater than or equal to 70 years) on outcome in a group of patients with endometrial carcinoma who were treated with simple hysterectomy followed by adjuvant radiation therapy (RT). METHODS. Between November 1987 and May 2000, 405 patients with International Federation of Gynecology and Obstetrics (FIGO) Stage IB-II endometrial carcinoma were treated with postoperative RT. Intravaginal RT alone was given to 77% of patients (median dose, 21grays [Gy] given in 3 fractions). Additional postoperative external beam radiation therapy (EBRT) was given to 23% of patients (median dose, 45 Gy). Eighty-four patients were age 70 years and 321 patients were age < 70 years. The two groups were well balanced with regard to race, comprehensive surgical staging, aggressive histology, lymphovascular invasion, lower uterine segment involvement, cervical involvement, and the use of postoperative EBRT. Significantly more patients in the age less than or equal to 70 years group had other comorbidities such as obesity, diabetes mellitus, or hypertension (P = 0.02) and were found to have deep (> 50%) myornetrial invasion (P = 0.008). RESULTS. With a median follow-up time of 48 months, the 5-year locoregional control (LRC), disease-free survival (DFS), and overall survival (OS) rates were 95%, 91%, and 90% respectively. On multivariate analysis, poor LRC was found to be correlated with age greater than or equal to 70 years (P = 0.019) and lymphovascular invasion (P = 0.001). Poor DFS was found to be correlated with age greater than or equal to 70 years (P = 0.03), lymphovascular invasion (P = 0.01), and aggressive histology (P = 0.001). Similarly, poor OS was found to correlate with age 70 years (P = 0.001), lymphovascular invasion (P = 0.01), aggressive histology (P = 0.01), and cervical involvement (P = 0.02). The same factors that were found to correlate with OS (age greater than or equal to 70 years, lymphovascular involvement, aggressive histology, and cervical involvement) also appeared to correlate with disease-specific survival (P = 0.03, P = 0.008, P = 0.001, and P = 0.04, respectively). The 5-year actuarial rates of Radiation Therapy Oncology Group late complications that were greater than or equal to Grade 3 (gastrointestinal tract, genitourinary tract, or vagina) were 3% in both groups. CONCLUSIONS. Even when treated in a similar fashion, endometrial carcinoma patients age greater than or equal to 70 years appear to fare worse than younger patients independent of other poor prognostic factors. The rate of complications from adjuvant RT, despite a higher rate of comorbidity in elderly patients, was found to be similar in both age groups. Endometrial carcinoma appears to be intrinsically more aggressive in older patients, thus mandating further improvement in their treatment strategies. (C) 2003 American Cancer Society.
引用
收藏
页码:2368 / 2377
页数:10
相关论文
共 34 条
  • [1] Abeler VM, 1996, CANCER, V78, P1740, DOI 10.1002/(SICI)1097-0142(19961015)78:8<1740::AID-CNCR14>3.0.CO
  • [2] 2-Y
  • [3] ABELER VM, 1991, CANCER, V67, P3093, DOI 10.1002/1097-0142(19910615)67:12<3093::AID-CNCR2820671226>3.0.CO
  • [4] 2-L
  • [5] Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?
    Alektiar, KM
    McKee, A
    Lin, O
    Venkatraman, E
    Zelefsky, MJ
    McKee, B
    Hoskins, WJ
    Barakat, RR
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (01): : 79 - 85
  • [6] Intravaginal high-dose-rate brachytherapy for Stage IB (FIGO Grade 1, 2) endometrial cancer
    Alektiar, KM
    McKee, A
    Venkatraman, E
    McKee, B
    Zelefsky, MJ
    Mychalczak, BR
    Hoskins, WJ
    Barakat, RR
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 53 (03): : 707 - 713
  • [7] Gynecological malignancies in elderly patients: Is age 70 a limit to standard-dose chemotherapy? An Italian retrospective toxicity multicentric study
    Ceccaroni, M
    D'Agostino, G
    Ferrandina, G
    Gadducci, A
    Di Vagno, G
    Pignata, S
    Poerio, A
    Salerno, MG
    Fanucchi, A
    Lapresa, MT
    Tambaro, R
    Scambia, G
    [J]. GYNECOLOGIC ONCOLOGY, 2002, 85 (03) : 445 - 450
  • [8] COX DR, 1972, J R STAT SOC B, V34, P187
  • [9] CREASMAN WT, 2001, J EPIDEMIOL BIOSTAT, V6, P45
  • [10] The morbidity of treatment for patients with stage I endometrial cancer:: Results from a randomized trial
    Creutzberg, CL
    van Putten, WLJ
    Koper, PC
    Lybeert, MLM
    Jobsen, JJ
    Wárlám-Rodenhuis, CC
    De Winter, KAJ
    Lutgens, LCHW
    van den Bergh, ACM
    van der Steen-Banasik, E
    Beerman, H
    van Lent, M
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (05): : 1246 - 1255